White label ELPA - ClinicalTrials.eu

Study of Durvalumab with Radiation Therapy for Patients with Early Stage Non-Small Cell Lung Cancer and Osimertinib for Those with EGFR Mutation

Not recruiting

3 1 1
Investigated Drugs:
+2
Study comparing stem cell transplantation versus alemtuzumab, cladribine or ocrelizumab in patients with aggressive relapsing-remitting multiple sclerosis

Not recruiting

3 1 1 1
Investigated Diseases:
- Relapsing-remitting multiple sclerosis
Investigated Drugs:
Study on the Safety and Effectiveness of Bezuclastinib for Patients with Advanced Systemic Mastocytosis

Not recruiting

2 1 1
Investigated Drugs:
- 3,4-Dimethyl-N-(2-Phenyl-1H-Pyrrolo[2,3-B]Pyridin-5-Yl)-1H-Pyrazole-5-Carboxamide
+3
Study of BAN2401 (lecanemab) in people with early stage Alzheimer’s disease to evaluate its effectiveness in preventing disease progression

Not recruiting

3 1 1 1
Investigated Drugs:
Study on Eye Health During Treatment with Mirvetuximab Soravtansine, Brimonidine Tartrate, and Prednisolone Acetate for Patients with Recurrent Ovarian Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Ovarian cancer
Investigated Drugs:
Study on the Effectiveness and Safety of CHF 5993 Compared to CHF 1535 for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Not recruiting

3 1
Investigated Diseases:
- Chronic obstructive pulmonary disease
Investigated Drugs:
Study of Paclitaxel, Carboplatin, and Durvalumab with or without Oleclumab for Patients with Untreated Advanced Triple-Negative Breast Cancer

Not recruiting

1 1 1 1
Investigated Diseases:
Investigated Drugs:
Study of Trastuzumab Deruxtecan for Patients with HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer After Trastuzumab Treatment

Not recruiting

3 1 1 1
Investigated Diseases:
- Adenocarcinoma gastric
Investigated Drugs:
+4
Study of Tamibarotene and Azacitidine Treatment in Newly Diagnosed Adults with RARA-positive Higher-risk Myelodysplastic Syndrome (MDS)

Not recruiting

3 1 1
Investigated Diseases:
- Myelodysplastic syndrome
Investigated Drugs:
- Tamibarotene
- Azacitidine
+3
Study of Tiragolumab, Atezolizumab, and Pembrolizumab for Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer

Not recruiting

4 1 1
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies